Peptide MS/MS Sequencing: b/y Ions and Peptide Mapping

Peptide MS/MS sequencing goes one step beyond intact mass: instead of asking whether a molecule has the right mass, it asks whether the residues are in the right order. This article explains how fragment ions form, how to read a b/y ladder, how enzymatic peptide mapping works, and where tandem MS reaches its limits.

From intact mass to sequence

An intact mass measurement confirms that a peptide's elemental composition is consistent with the expected sequence. It cannot show whether two residues have been swapped, because the swapped molecule has exactly the same mass. Tandem mass spectrometry (MS/MS) addresses this by adding a second stage of analysis:

1. Precursor selection. The first analyzer isolates one m/z, typically a chosen charge state of the peptide.
2. Fragmentation. The isolated ions are activated, most commonly by collisions with an inert gas.
3. Fragment analysis. The second analyzer records the m/z of the resulting product ions.

Instruments that do this include triple quadrupoles, ion traps, Q-TOFs and Orbitrap hybrids, most often coupled to LC with electrospray ionization. For background on that front end, see LC-MS vs MALDI-TOF.

How b and y ions form

In collision-induced dissociation (CID) and the related beam-type method often called HCD, a mobile proton moves along the backbone and promotes cleavage of amide bonds. Each cleavage splits the peptide into two pieces; whichever piece keeps the charge is detected.

• b ions contain the N-terminus. A b ion's m/z (singly charged) is the sum of its residue masses plus about 1.007 for the added proton.
• y ions contain the C-terminus. A y ion's m/z is the sum of its residue masses plus water (18.011) plus a proton, about 19.018 in total.

The naming convention, introduced by Roepstorff and Fohlman and extended by Biemann, also includes a, c, x and z ions for cleavage at other backbone bonds. Common secondary features include a ions (b minus CO, 27.995), neutral losses of water (−18.011) or ammonia (−17.027), and low-mass immonium ions that indicate specific residues, such as m/z 120.08 for phenylalanine and 86.10 for leucine or isoleucine.

Other fragmentation methods

Electron-transfer dissociation (ETD) and electron-capture dissociation (ECD) cleave the N–Cα bond instead, producing c and z• ions. They work best on precursors with higher charge states and tend to keep labile modifications attached to the residue that carries them.

Reading a peptide MS/MS sequencing ladder: a worked example

Consider two hypothetical model pentapeptides, ALGFR and AGLFR. They contain the same residues and share an [M+H]⁺ of m/z 563.33, so intact MS cannot tell them apart. Their singly charged fragment ions, calculated from monoisotopic residue masses, are:

Ion	ALGFR	AGLFR	Ion	ALGFR	AGLFR
b1	72.04	72.04	y1	175.12	175.12
b2	185.13	129.07	y2	322.19	322.19
b3	242.15	242.15	y3	379.21	435.27
b4	389.22	389.22	y4	492.29	492.29

The b2 and y3 ions differ, and the mass steps between neighboring ions identify the residues in order. For ALGFR, b2 − b1 is 113.08 (Leu or Ile); for AGLFR it is 57.02 (Gly). Reading consecutive differences in both series, and checking that b and y ions are complementary (b_i + y_n−i equals the precursor [M+H]⁺ plus one proton), gives a self-consistent sequence. In practice b1 ions are often weak or absent, and y ions frequently dominate for peptides with a C-terminal Arg or Lys.

Practical points

• Cleavage N-terminal to proline is often enhanced, which can make one fragment dominate.
• Multiply charged fragments appear at lower m/z; high-resolution isotope spacing (1/z) reveals their charge.
• Full coverage is rare; a good spectrum shows enough overlapping b and y ions to confirm every position or every residue pair.

What MS/MS can and cannot distinguish

Question	Can CID/HCD MS/MS resolve it?	Notes
Swapped or scrambled residues	Yes	Different fragment ladders, as in the example above
Location of a modification	Usually	The mass shift appears in fragments that contain the modified residue
Gln vs Lys (128.059 vs 128.095)	Yes, with high resolution	A 0.036 Da difference
Gly-Gly vs Asn; Gly-Ala vs Gln	Only if the intervening fragment is observed	Identical elemental composition
Leu vs Ile	Not by CID/HCD alone	Isobaric; side-chain fragments from ETD-based methods (w ions) can differentiate
Asp vs isoAsp	Difficult by CID	ETD can give characteristic fragments; chromatography also separates them
L- vs D-amino acids	Generally no	Use chiral amino acid analysis or chromatographic comparison with a reference

Because diastereomers and isobaric residues can escape MS/MS, sequence confirmation is strongest when combined with orthogonal data such as HPLC comparison and amino acid analysis.

Enzymatic digestion and peptide mapping

Short synthetic peptides can usually be sequenced directly. Longer peptides and proteins produce fragment spectra too complex to interpret completely, so they are first cleaved with a specific protease, and the resulting fragments are separated by LC and analyzed by MS/MS. The pattern of fragments, its "map", serves as an identity fingerprint, which is why peptide mapping is described in ICH Q6B and USP <1055>.

Enzyme	Cleaves C-terminal to	Notes
Trypsin	Lys, Arg	Cleavage reduced when followed by Pro
Lys-C	Lys	Active under denaturing conditions
Glu-C	Glu (and Asp in phosphate buffer)	Buffer-dependent specificity
Chymotrypsin	Phe, Tyr, Trp (and to a lesser extent Leu, Met)	Broader, less predictable specificity

Asp-N is also used and cleaves N-terminal to aspartic acid. For molecules with disulfide bonds, comparing digests prepared with and without reduction shows which cysteines are linked: disulfide-linked fragments disappear on reduction and are replaced by their individual chains. For a broader look at which impurities produce which mass shifts, see common impurities in synthetic peptides.

Frequently asked questions

What is the difference between b and y ions?

Both come from cleavage of an amide bond. b ions keep the N-terminal portion and y ions keep the C-terminal portion, including the terminal carboxyl group plus water.

Can MS/MS tell leucine from isoleucine?

Not with standard collision-based fragmentation, because the two residues have identical mass. Specialized electron-based methods or amino acid analysis are used when the distinction matters.

Do short synthetic peptides need enzymatic digestion?

Usually not. Peptides of modest length can typically be fragmented and sequenced directly, while digestion is mainly used for longer peptides and proteins.

References

1. Roepstorff P, Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomedical Mass Spectrometry (1984).
2. Steen H, Mann M. The ABC's (and XYZ's) of peptide sequencing. Nature Reviews Molecular Cell Biology (2004).
3. ICH Q6B. Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products.
4. USP <1055> Biotechnology-Derived Articles—Peptide Mapping.